News
About the company
Investors & Media
Research and development
Generic Products
EN
PL
EN
PL
News
About the company
Investors & Media
Research and development
Generic Products
Press releases
2021
February
Celon Pharma Announces Successful Completion of Phase 1A Trial of CPL’116, JAK-ROCK Inhibitor.
Read more...
January
Celon Pharma Announces Positive Falkieri Phase II Results in Treatment-Resistant Bipolar Depression
Read more...
2019
February
Celon Pharma on track to conquer the global antidepressant market worth between USD 2.5 and 4 billion.
Read more...
2018
November
Celon Pharma S.A. initiates clinical development of its own cutting edge anti-cancer drug – an FGFR inhibitor
Read more...
January
Completed administration of the Esketamine-based drug to all subjects of the first part of the phase 1 trial
Read more...
2017
November
Celon Pharma has positively concluded the decentralised procedure (DCP) for Salmex on Scandinavian markets
Read more...
Celon Pharma S.A. begins a clinical programme for Esketamine in the treatment of drug-resistant depression
Read more...
Stable business foundation with a good prospect for presence in new European markets.
Read more...
September
Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017
Read more...
July
Celon Pharma S.A. submitted an application for a permit to build a Research and Development Centre in Kazuń Nowy.
Read more...
Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products
Read more...
May
Celon Pharma S.A. reports a stable first quarter of 2017 and its plans for the dynamic development of the Company's operations in the current year.
Read more...
A new Research and Development Centre of Celon Pharma S.A.
Read more...
Global commercialisation of Celon Pharma S.A.’s innovative portfolio
Read more...
April
Celon Pharma S.A. reports a steadily growing revenue and profit for 2016
Read more...
February
Celon Pharma S.A. received an award for the best stock debut in 2016
Read more...